NOVAAGRI
Nova Agritech Limited
Agri-input products including soil-health and crop-protection solutions
Commodities›Chemicals›Fertilizers & Agrochemicals›Fertilizers
novaagri.in(opens the company website in a new tab)Key metrics
Price as of 2026-10-16
Full years shown; sign in free for the trailing twelve months. Learn about these metrics →
Price & valuation
Share price and valuation multiples (P/E, P/B and more) over time.
Loading price history…
Compare with peers
Loading peers…
What you need to know
Nova Agritech makes and sells soil health management, crop nutrition and crop protection products, an agri-input business in the fertilizer industry that supplies farmers in India.
Company snapshot
16thBy market cap
Ranked among 19 companies in Fertilizers.
What we see
- ✓Debt-to-equity of 0.22x — the company is largely funded by its own money, not borrowed funds.
- ✗Over the last three years operations used more cash than they brought in, despite an operating profit — the business is not yet turning its profit into cash.
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 78 Cr | 71 Cr | 42 Cr | 83 Cr | 88 Cr | 81 Cr | 47 Cr | 92 Cr | 67 Cr | 56 Cr | 60 Cr |
| Operating expenses (approx.) | 63 Cr | 61 Cr | 36 Cr | 71 Cr | 73 Cr | 72 Cr | 41 Cr | 80 Cr | 60 Cr | 52 Cr | 54 Cr |
| EBITDA | 15 Cr | 10 Cr | 6 Cr | 12 Cr | 15 Cr | 10 Cr | 5 Cr | 12 Cr | 6 Cr | 4 Cr | 6 Cr |
| OPM % | 19.2% | 14.0% | 14.1% | 14.4% | 17.4% | 11.8% | 11.5% | 13.0% | 9.6% | 6.4% | 10.4% |
| Other income | 0.0018 Cr | 0.0063 Cr | 0.55 Cr | 0.49 Cr | 0.19 Cr | 1 Cr | 0.09 Cr | 0.03 Cr | 0.04 Cr | 0.0040 Cr | 0.14 Cr |
| Interest | 2 Cr | 2 Cr | 1 Cr | 2 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr | 1 Cr |
| Depreciation | 0.52 Cr | 0.44 Cr | 0.36 Cr | 0.47 Cr | 0.48 Cr | 0.52 Cr | 0.41 Cr | 1 Cr | 2 Cr | 2 Cr | 1 Cr |
| Profit before tax | 12 Cr | 7 Cr | 5 Cr | 10 Cr | 14 Cr | 9 Cr | 4 Cr | 9 Cr | 3 Cr | 0.89 Cr | 4 Cr |
| Tax % | 21.6% | -17.8% | 11.3% | 34.5% | 24.2% | 35.3% | 17.1% | 28.4% | 24.1% | 75.2% | 16.8% |
| Net profit | 10 Cr | 8 Cr | 4 Cr | 7 Cr | 11 Cr | 6 Cr | 3 Cr | 7 Cr | 3 Cr | 0.22 Cr | 3 Cr |
| EPS (₹) | ₹1.54 | ₹1.23 | ₹0.47 | ₹0.75 | ₹1.17 | ₹0.65 | ₹0.36 | ₹0.73 | ₹0.28 | ₹0.02 | ₹0.36 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 161 Cr | 186 Cr | 211 Cr | 252 Cr | 294 Cr | 262 Cr | Sign in free for the trailing twelve months |
| Operating expenses (approx.) | 143 Cr | 158 Cr | 172 Cr | 208 Cr | 251 Cr | 234 Cr | Sign in free for the trailing twelve months |
| EBITDA | 18 Cr | 28 Cr | 39 Cr | 44 Cr | 43 Cr | 27 Cr | Sign in free for the trailing twelve months |
| OPM % | 11.1% | 15.0% | 18.4% | 17.6% | 14.5% | 10.4% | Sign in free for the trailing twelve months |
| Other income | 0.28 Cr | 0.02 Cr | 0.38 Cr | 0.04 Cr | 2 Cr | 0.17 Cr | Sign in free for the trailing twelve months |
| Interest | 7 Cr | 7 Cr | 9 Cr | 9 Cr | 5 Cr | 5 Cr | Sign in free for the trailing twelve months |
| Depreciation | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 2 Cr | 5 Cr | Sign in free for the trailing twelve months |
| Profit before tax | 9 Cr | 18 Cr | 28 Cr | 33 Cr | 38 Cr | 18 Cr | Sign in free for the trailing twelve months |
| Tax % | 27.3% | 25.8% | 27.2% | 15.2% | 28.0% | 27.4% | Sign in free for the trailing twelve months |
| Net profit | 6 Cr | 14 Cr | 20 Cr | 28 Cr | 27 Cr | 13 Cr | Sign in free for the trailing twelve months |
| EPS (₹) | ₹1.00 | ₹2.18 | ₹3.27 | ₹4.20 | ₹3.05 | ₹1.43 | Sign in free for the trailing twelve months |
| Dividend payout % | — | — | — | 0.0% | 0.0% | 0.0% | Sign in free for the trailing twelve months |
The latest four quarters added up, next to each full year
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 13 Cr | 13 Cr | 13 Cr | 18 Cr | 19 Cr | 19 Cr |
| Reserves | 17 Cr | 31 Cr | 51 Cr | 175 Cr | 201 Cr | 214 Cr |
| Borrowings | 51 Cr | 64 Cr | 71 Cr | 61 Cr | 55 Cr | 50 Cr |
| Other liabilities | 67 Cr | 53 Cr | 46 Cr | 44 Cr | 61 Cr | 62 Cr |
| Total liabilities | 147 Cr | 160 Cr | 181 Cr | 298 Cr | 336 Cr | 345 Cr |
| Fixed assets (net) | 16 Cr | 17 Cr | 16 Cr | 14 Cr | 15 Cr | 49 Cr |
| CWIP | — | 0.05 Cr | 0.63 Cr | 0.75 Cr | 18 Cr | 0 Cr |
| Investments | 0.0001 Cr | 0.0001 Cr | 0.0001 Cr | 0.0001 Cr | 0.0001 Cr | 0.0001 Cr |
| Inventories | 35 Cr | 37 Cr | 42 Cr | 50 Cr | 64 Cr | 88 Cr |
| Trade receivables | 85 Cr | 93 Cr | 106 Cr | 123 Cr | 180 Cr | 185 Cr |
| Cash & bank | 0.32 Cr | 2 Cr | 3 Cr | 63 Cr | 6 Cr | 0.27 Cr |
| Other assets | 11 Cr | 12 Cr | 14 Cr | 47 Cr | 52 Cr | 22 Cr |
| Total assets | 147 Cr | 160 Cr | 181 Cr | 298 Cr | 336 Cr | 345 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operating activity | 5 Cr | 2 Cr | 5 Cr | 0.79 Cr | -18 Cr | 2 Cr |
| Cash from investing | -3 Cr | -4 Cr | -2 Cr | -23 Cr | -26 Cr | 1 Cr |
| Cash from financing | -2 Cr | 3 Cr | -2 Cr | 82 Cr | -12 Cr | -9 Cr |
| Net cash flow | 0.23 Cr | 1 Cr | 2 Cr | 59 Cr | -57 Cr | -6 Cr |
| Free cash flow (OCF − Capex) | 2 Cr | -2 Cr | 3 Cr | 0.79 Cr | -18 Cr | 2 Cr |
Ratios
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| ROCE % | 19.9% | 23.8% | 27.2% | 16.7% | 15.8% | 8.0% |
| ROE % | 21.4% | 31.7% | 32.1% | 14.7% | 12.5% | 5.5% |
| Debtor days | 193 | 182 | 183 | 178 | 223 | 258 |
| Inventory days | 131 | 110 | 127 | 111 | 109 | 155 |
| Days payable | 171 | 97 | 83 | 58 | 76 | 89 |
| Cash conversion cycle | 152 | 195 | 227 | 231 | 256 | 324 |
| OCF / EBITDA % | 29.0% | 8.9% | 14.1% | 1.8% | -43.2% | 6.2% |
| OCF / EBITDA % (3 years) | — | — | 15.5% | 7.9% | -9.7% | -14.0% |
| Debt / equity | 1.74 | 1.49 | 1.11 | 0.32 | 0.25 | 0.22 |
| Current ratio | 1.32 | 1.50 | 1.60 | 2.85 | 2.63 | 2.65 |
| Net debt / EBITDA | 2.84 | 2.25 | 1.75 | -0.04 | 1.13 | 1.83 |